MULTI-STAGE SNARE
K133513 · United States Endoscopy Group, Inc. · FDI · Dec 20, 2013 · Gastroenterology, Urology
Device Facts
| Record ID | K133513 |
| Device Name | MULTI-STAGE SNARE |
| Applicant | United States Endoscopy Group, Inc. |
| Product Code | FDI · Gastroenterology, Urology |
| Decision Date | Dec 20, 2013 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 876.4300 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The US Endoscopy Multi-Stage snare is an elcctrosurgical device designed to be used to endoscopically grasp, dissect and transect tissue during Gastrointestinal (GI) endoscopic procedures.
Device Story
Multi-stage snare is an electrosurgical accessory for GI endoscopy. Device used by physicians to grasp, dissect, and transect tissue during endoscopic procedures. Operates via electrosurgical energy to cut or coagulate tissue. Device is a manual instrument; no automated processing or software involved. Benefits include facilitating tissue removal or biopsy during standard GI interventions.
Clinical Evidence
Bench testing only.
Technological Characteristics
Electrosurgical snare for endoscopic use. Class II device, product code FDI. Manual mechanical operation with electrosurgical energy delivery.
Indications for Use
Indicated for use in patients undergoing gastrointestinal endoscopic procedures requiring tissue grasping, dissection, and transection.
Regulatory Classification
Identification
An endoscopic electrosurgical unit and accessories is a device used to perform electrosurgical procedures through an endoscope. This generic type of device includes the electrosurgical generator, patient plate, electric biopsy forceps, electrode, flexible snare, electrosurgical alarm system, electrosurgical power supply unit, electrical clamp, self-opening rigid snare, flexible suction coagulator electrode, patient return wristlet, contact jelly, adaptor to the cord for transurethral surgical instruments, the electric cord for transurethral surgical instruments, and the transurethral desiccator.
Related Devices
- K151197 — Lariat snare · United States Endoscopy Group, Inc. · Jul 6, 2015
- K200745 — Lariat, Hot/Cold Snare · United States Endoscopy Group, Inc. · Apr 21, 2020
- K140763 — MONOFILAMENT POLYPECTOMY SNARE · United States Endoscopy · Apr 24, 2014
- K152035 — iSnare system-Lariat · United States Endoscopy Group, Inc. · Oct 15, 2015
- K172734 — Single Use Electrosurgical Snare SD-400 · Olympus Medical Systems Corp. · Dec 7, 2017
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the seal of the Department of Health & Human Services USA. The seal is circular, with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the top half of the circle. In the center of the seal is an abstract symbol that resembles an eagle or bird with outstretched wings. The symbol is composed of three curved lines that converge at the bottom.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 20, 2013
United States Endoscopy Group, Inc. Carroll Martin Director, Regulatory Affairs 5976 Heisley Road Mentor, OH 44060
Re: K133513
> Trade/Device Name: Multi-stage snare Regulation Number: 21 CFR 876.4300 Regulation Name: Endoscopic Electrosurgical Unit and Accessories Regulatory Class: Class II Product Code: FDI Dated: November 25, 2013 Received: November 26, 2013
Dear Carroll Martin,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
{1}------------------------------------------------
Page 2 - Carroll Martin
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
## Elaine Blyskun
for Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
United States Endoscopy Group, Inc.
SIG(k) Premarket Notlfication: Special Multi-Stage snare
## INDICATIONS FOR USE
510(k) Number (if known); Kl33513
Device Name: Multi-Stage snare
Indications for Use:
The US Endoscopy Multi-Stage snare is an elcctrosurgical device designed to be used to endoscopically grasp, dissect and transect tissue during Gastrointestinal (GI) endoscopic procedures.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use X (Part 21 CFR 801 Subpart D) OR
Over-The-Counter Use (21 CFR 801 Subpart C)
## Elaine Blyskun for Benjamin Fisher
Page _ 1_ of _ l